Metabolic consequences present new challenge.
D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003327:Coronary Disease / Q000139:chemically induced; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D019247:HIV Wasting Syndrome / Q000150:complications; D006801:Humans; D006937:Hypercholesterolemia / Q000139:chemically induced; D008060:Lipodystrophy / Q000139:chemically induced* / Q000150:complications
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors